Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
British Journal of Haematology|November 11, 1999
High-dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemiaR Desikan, M Dhodapkar, D Siegel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodesT Mahfouz, M H Miceli, F Saghafifar, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 11, 2002
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complicationsM Zangari, F Saghafifar, E Anaissie, et al.Bone Marrow Transplantation|March 14, 2000
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan aloneK R Desikan, G Tricot, M Dhodapkar, et al.Blood|December 24, 1998
Age is not a prognostic variable with autotransplants for multiple myelomaD S Siegel, K R Desikan, J Mehta, et al.Bone Marrow Transplantation|December 12, 2002
Transplantation as salvage therapy for high-risk patients with myeloma in relapseC-K Lee, B Barlogie, M Zangari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myelomaK R Desikan, B Barlogie, S Jagannath, et al.Journal of Neurology|July 15, 2000
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study GroupG Comi, L Kappos, M Clanet, et al.British Journal of Haematology|September 21, 2001
Results of autologous stem cell transplant in multiple myeloma patients with renal failureA Badros, B Barlogie, E Siegel, et al.British Journal of Haematology|February 13, 2001
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor aloneK R Desikan, G Tricot, N C Munshi, et al.Pageof 6